Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Subscribe
Expertise
Industry
Location
Media Type
Published Date
Created
Thought Leadership

Dr. Chad Perlyn is Building Clinicians of the Future as He Leads NSU Florida's AMC
March 12, 2026
How do we prepare tomorrow's physicians for a system defined by constant change? Chad Perlyn, M.D., PhD, FACS, EVP and Chief Medical Officer of NSU Florida and Dean of NSU MD, joins A&M Healthcare Industry Group's Jamie LaGuardia-Frie and David Shulkin, M.D. to share how their academic medical center is reimagining education to prepare physicians for a rapidly evolving healthcare landscape.
Thought Leadership

How Bankruptcy Restructurings Trigger Inversion Tax Risks
March 12, 2026
In a recent ABI Journal article, Kevin M. Jacobs and Devon Bodoh explain how cross-border bankruptcy restructurings can unintentionally trigger U.S. tax “inversion” rules, creating significant and often irreversible tax consequences.
Thought Leadership

Asia Financial Services M&A 2026: Wealth & Asset Management and Private Equity
March 11, 2026
Read our Wealth & Asset Management and Private Equity M&A extract from our "Keeping up with Momentum - FSIG Financial Services M&A in 2026" report. Discover: Increasing Asian high-net-worth population driving inbound investment; Expected consolidation across the hyper-fragmented asset management and private markets GP landscape.
Thought Leadership

Navigating the 2026 Energy Crisis: Beyond the Headlines

March 10, 2026
We are currently witnessing a high stake "game changer" for Iran, the Middle East, and global energy markets. The developments unfolding this March are more than just transient headlines; they could represent a fundamental, structural shift in the regional and geopolitical landscape.
Thought Leadership

PN3 Served Its Purpose. Now It Needs Reform
March 6, 2026
This article focuses on the evolving debate around Press Note 3 (PN3), examining its achievements, the impact of prolonged approvals on investor confidence, and the case for reforms anchored in clearer thresholds, time-bound approvals, and exemptions for small investments.